Stay updated on LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial

Sign up to get notified when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Website updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T17:49:56.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T14:49:01.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1. These are administrative UI/text updates and do not alter study data or participation information.
    Difference
    0.4%
    Check dated 2026-02-11T01:57:59.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added a government funding lapse notice informing users that operations may be affected and directing them to cc.nih.gov for current updates; the NIH Clinical Center remains open. Footer revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:43:29.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    UI updates include showing the glossary by default, updating the label to 'Last Update Submitted that Met QC Criteria', adding 'No FEAR Act Data' text, and updating the revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T21:06:12.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The update removes extensive IPD sharing information and related policy sections from the Study Details page; core study information such as eligibility, interventions, and locations remains available. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    20%
    Check dated 2026-01-20T16:54:38.000Z thumbnail image

Stay in the know with updates to LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.